Multiple Myeloma Clinical Trial
Digital Life Coaching for Myeloma Patients Undergoing Transplantation
Summary
This is the first study of digital life coaching (DLC) to engage patients during the peri-HCT period that is punctuated by intensive life changes. DLC may circumvent these limitations by combining the integrative cross-dimensional nature of life coaching with the advantages of mobile health technology. The purpose of this study is to evaluate whether ongoing participant engagement with a DLC platform is feasible for multiple myeloma (MM) patients actively undergoing hematopoietic stem cell transplantation (HCT).
Full Description
Participants will receive unlimited access to Pack Health's DLC platform during a 16-week period encompassing pre-HCT conditioning chemotherapy, post-HCT recovery, and 100-day follow-up. Participants will engage with Pack Health's DLC platform and complete quality of life assessments for 16 weeks beginning from enrollment. At the conclusion of the treatment period, participants will be asked to rate their satisfaction with the DLC platform
Primary Objective:
To evaluate the rate of ongoing participant engagement with a DLC platform during the study period
Secondary Objectives:
To assess quality of life among participants during the study period
To assess psychosocial distress among participants during the study period
To assess sleep disturbances among participants during the study period
To assess participant satisfaction with the DLC platform at the end of the study period
Exploratory Objectives:
To assess benzodiazepine and zolpidem-class drug usage for anxiety or insomnia among participants during the study period
To assess communications with treatment teams among participants during the study period
To assess 100-day clinical outcomes among participants at the end of the study period
Eligibility Criteria
Inclusion Criteria:
Confirmed diagnosis of one of the following (all referred to as MM in this protocol):
Multiple myeloma (ICD-10 code: C90.0)
Extramedullary plasmacytoma (ICD-10 code: C90.2)
Planned receipt of autologous HCT at our institution
Patients undergoing outpatient HCT will be eligible
Patients who received chemomobilization will be eligible
Age ≥ 18, as life coaches employed by the DLC vendor are not currently trained to work with pediatric patients
Exclusion Criteria:
Prior autologous HCT for any indication
Physician-assessed lack of sufficient English proficiency
Lack of ownership of a personal smartphone
Any serious and/or unstable pre-existing medical, psychiatric, or other condition that could interfere with participant's safety, provision of informed consent, or compliance with study procedures
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
San Francisco California, 94143, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.